India's pharmaceutical exports to the United States, which amount to nearly $10 billion each year, may face challenges as the US government has commenced an investigation
Johnson & Johnson's CEO has cautioned that any US tariffs on the pharmaceutical sector may result in medication shortages. The Trump administration has made it plain that it is considering utilizing the broad tariffs that were announced this month
The CDSCO has recently upgraded its online registration system and required all manufacturers of medical devices to re-submit their market standing...
According to recent information collected from the U.S. Food and Drug Administration (FDA), major leading pharmaceutical firms in India are recalling...
An intralogistics and warehouse automation solutions provider, specializes in the design and implementation of advanced solutions that optimize storage, sorting, and order fulfillment processes across various industries
The United States president Donald Trump announced that the U.S will shortly introduce a "major" tariff on pharmaceutical imports. “We are going to be announcing very shortly a major tariff on
Standard Operating Procedures (SOP) have been framed by the CDSCO for drugs manufactured in Special Economic Zones for transfer...
In terms of using these medical devices, India imports almost 80 to 85 percent of them; hence, the government and the private sector are prompted towards the idea...
The Indian medical devices industry is facing a major challenge as the US imposes a 26% tariff on exports, impacting a sector striving to replicate the success of India’s pharmaceutical industry. With India’s medical device exports to the US valued a
The Association Indian Medical Device Industry (AiMED) congratulates the government's announcement to operationalise the...
, CDSCO.jpg)
